ClinicalTrials.Veeva

Menu

The Role of Affect Regulation and Self-presentation in the Expressive Writing Intervention

U

University of Toronto

Status

Completed

Conditions

Posttraumatic Stress Disorders

Treatments

Behavioral: Control
Behavioral: Expressive Writing

Study type

Interventional

Funder types

Other

Identifiers

NCT00831727
SSHRC 767-2007-2210-4
23614

Details and patient eligibility

About

The purpose of the present study is twofold. First, we will attempt to examine the role that emotion regulation and self-presentation play as potential moderators in the expressive writing paradigm. We hypothesize that expressive writing participants who demonstrate greater abilities to regulate their emotions at baseline will improve more on our outcome measures. We also hypothesize that those expressive writing participants who demonstrate higher levels of self-presentation at baseline will improve less on our outcome measures.

The second aim of the study has two related objectives. First, we will attempt to investigate whether the expressive writing intervention can increase and enhance an individual's emotion regulation abilities. Related to this, we will then go on to examine whether emotion regulation can be looked at as a potential mechanism of action in the expressive writing procedure. Related to these two objectives, we hypothesize that in comparison to the control group, participants in the expressive writing condition will show increases in their ability to regulate their emotions from baseline to four week follow up. Moreover, we predict that greater gains in emotion regulation abilities for the expressive writing participants will be significantly related to greater gains in outcome measures.

Enrollment

75 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Fluent in English
  • Previously experienced trauma (not current or ongoing; excluding bereavement)
  • Currently experiencing trauma-related distress

Exclusion criteria

  • Currently involved in psychotherapy
  • Currently taking psychotropic medications
  • Imminent threat to self or others

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

75 participants in 2 patient groups, including a placebo group

Expressive Writing
Experimental group
Treatment:
Behavioral: Expressive Writing
Control
Placebo Comparator group
Treatment:
Behavioral: Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems